Aspen Pharma Ireland Limited (“Aspen”), a subsidiary of Aspen Pharmacare Holdings Limited, has entered into an exclusive licensing agreement (“Agreement”) with UK-based specialist pharmaceutical company Viramal Limited (“Viramal”) for an innovative Women’s Health portfolio. Under the agreement, Aspen will have exclusive rights to launch and commercialize selected products from Viramal’s portfolio in Europe, the Middle East, Brazil and Mexico.
Aspen concludes an exclusive Women’s Health portfolio licensing agreement with Viramal